Ser313
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser313  -  SNAP-91 (human)

Site Information
SPATTVTsPNSTPAK   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 454326

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 2 ) , mutation of modification site ( 1 )
Disease tissue studied:
cervical cancer ( 1 ) , cervical squamous cell carcinoma ( 1 ) , gastric cancer ( 1 ) , gastric carcinoma ( 1 ) , FTLD ( 2 )
Relevant cell line - cell type - tissue:
'brain, cerebral cortex' ( 2 ) , KATO III (gastric) ( 1 ) , SiHa (squamous) ( 1 )

Downstream Regulation
Effects of modification on SNAP-91:
molecular association, regulation ( 1 )
Induce interaction with:
PLD1 (human) ( 1 )

References 

1

Cho JH, et al. (2011) The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1. Cancer Lett 302, 144-54
21296491   Curated Info

2

Herskowitz JH, et al. (2010) Phosphoproteomic Analysis Reveals Site-Specific Changes in GFAP and NDRG2 Phosphorylation in Frontotemporal Lobar Degeneration. J Proteome Res 9, 6368-79
20886841   Curated Info